Chair Rodgers: GAO Gain-of-Function Research Report Affirms Our Concerns with HHS P3CO Framework
Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) offered the following statement after the Government Accountability Office issued a report titled “HHS Could Improve Oversight of Research Involving Enhanced Potential Pandemic Pathogens,” which is commonly referred to as “gain-of-function" research.
“Today’s watchdog report affirms many of my concerns with the secretive HHS board that purportedly reviews risky research projects from federal agencies. So far, the risky research proposals of concern only appear to be funded by the National Institutes of Health, specifically by the National Institute of Allergy and Infectious Diseases. The American public deserve to know to what extent their tax dollars are being used to fund pathogenic research that has the potential to cause a pandemic. Whether or not the U.S. government played any role—directly or indirectly—in the creation of COVID-19, our committee’s investigation is uncovering a host of issues that require more attention. Thankfully, we were able to enact some commonsense prohibitions regarding where and how this type of research is funded, but we will continue pushing for more accountability and oversight to start rebuilding public trust in these research agencies.”
KEY EXCERPT FROM GAO REPORT: By working with its funding agencies to identify and share non-sensitive information about how HHS, in coordination with its funding agencies, conducts reviews and makes funding recommendations, researchers, Congress, and the public would have greater assurance that departmental review provides meaningful and effective suggestions to address biosafety and biosecurity concerns about research involving enhanced potential pandemic pathogens. Moreover, doing so could enhance public confidence in the department’s oversight as well as ensure the agency’s goal to exemplify and promote the highest level of scientific integrity, public accountability, and social responsibility in the conduct of science.
Chair Rodgers, along with Reps. Brett Guthrie (R-KY) and Morgan Griffith (R-VA) wrote to Department of Health and Human Services Secretary Xaiver Becerra in April of 2022, raising concerns on the “flawed and overly secretive review process of whether risky research for potential pandemic pathogens can be conducted safely and have a justifiable benefit.”
KEY LETTER EXCERPT: “Dr. Chris Hassell, the HHS Deputy Assistant Secretary for Preparedness and Response and the chair of the HHS P3CO review committee, briefed the committee staff twice during the summer of 2021. During the briefings, when asked about the identities of the members, Dr. Hassell did not provide the names of the members of the review group. However, he indicated which agencies or departments were represented on the HHS P3CO Review Committee. Dr. Hassell noted there were members from the NIH on the review committee, but he specifically pointed out that the NIH members were from the Office of the Director and not from any of the NIH institutes or centers that would be funding entities to avoid conflict-of-interest concerns.
“The minority committee staff requested that HHS provide the names and affiliations of all members of the HHS P3CO review committee. In response, HHS provided some of the names of the HHS P3CO review committee, but on a confidential basis because of personal security concerns.”
You can read the full letter here.